Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Revista Do Instituto De Medicina Tropical De Sao Paulo|February 12, 2000
Partial chemical characterization of antigenic preparations of chromoblastomycosis agentsT F Barros, M A Resende
Canadian Journal of Microbiology|March 1, 1992
Fonsecaea pedrosoi: lipid composition and determination of susceptibility to amphotericin BM H Gomes, M A Resende
Canadian Journal of Microbiology|August 14, 1999
Use of RAPD (random amplified polymorphic DNA) to analyse genetic diversity of dematiaceous fungal pathogensR B Caligiorne, M A Resende, E Paiva, et al.
Medicina Cutanea Ibero-Latino-Americana|January 1, 1979
[Combination of 5-fluorocytosine and amphotericin B in the treatment of chromomycosis]C F Lopes, M A Resende, R J Alvarenga, et al.
Mycoses|November 1, 1992
Haematological alterations induced by biochemical fractions of Paracoccidioides brasiliensis in miceJ S Hamdan, M A Resende, S P Franzot, et al.
Memorias Do Instituto Oswaldo Cruz|January 1, 1993
Histopathological alterations induced by non-viable cells and biochemical fractions from Paracoccidioides brasiliensis in miceJ S Hamdan, O A Rocha, M A Resende, et al.
Letters in Applied Microbiology|July 27, 2007
Antifungal activity of the amyrin derivatives and in vitro inhibition of Candida albicans adhesion to human epithelial cellsS Johann, C Soldi, J P Lyon, et al.
Brazilian Journal of Microbiology : [Publication of the Brazilian Society for Microbiology]|September 14, 2013
Antifungal suscepitibility profile of candida spp. oral isolates obtained from denture wearersJ P Lyon, L M Moreira, M A G Cardoso, et al.
International Journal of Dermatology|June 1, 1978
Six years' experience in treatment of chromomycosis with 5-fluorocytosine,C F Lopes, R J Alvarenga, E O Cisalpino, et al.
Medical Mycology|January 27, 2000
In vitro susceptibility of chromoblastomycosis and phaeohyphomycosis agents to antifungal drugsR B Caligiorne, M A Resende, P H Melillo, et al.
Pageof 2